Document Detail


Differential action of two prolactin isoforms on ischemia and re-perfusion-induced arrhythmias in rats in vivo.
MedLine Citation:
PMID:  20924224     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: The different influences of one of the PRL isoforms (PRL I) on the cardiovascular system have been described in the past.
AIM: Our goal was to establish an appropriate iv dose of 2 PRL isoforms (PRL I and PRL II) in intact rats. After establishing this dose, PRL I (0.01 mg/kg) or PRL II (0.001 mg/kg) was administered in bolus 10 min before left anterior descending coronary artery occlusion (7 min) followed by re-perfusion (15 min). We then aimed to study and compare the effects of these isoforms on ischemia- and re-perfusion-induced arrhythmias in the ischemia and re-perfusion-induced arrhythmias model in rats.
MATERIALS AND METHODS: Mortality index, ventricular fibrillation and tachycardia (VF, VT) incidence and duration, systolic, diastolic, and mean arterial blood pressure, heart rate and myocardial index of oxygen consumption [pressure rate product (PRP)] were measured and calculated.
RESULTS: Both PRL isoforms reduced animal mortality (from 50 to 18.75 and 25%, respectively). PRL II significantly reduced VF incidence (to 25%) as well as VT duration (18.21±3.09) and these effects were markedly different from PRL I and from the control group (p<0.05). Both PRL reduced PRP in the recovery phase (p<0.05).
CONCLUSIONS: We proved that supraphysiological doses of PRL isoforms administered in bolus could protect against sudden cardiac death as well as severe arrhythmias episodes during re-perfusion. Because of PRL's positive influence on the cardiovascular system and as an endogenous, well-tolerated substance, it might be of potential clinical use.
Authors:
T F Krzeminski; K Mitrega; M Porc; M Zorniak; F Ryszka; Z Ostrowska; B Kos-Kudła
Related Documents :
18373594 - Activation delay and vt parameters in arrhythmogenic right ventricular dysplasia/cardio...
7681564 - Changing trends in therapy delivery with a third generation noncommitted implantable de...
9058854 - Ventricular tachycardia: pathophysiology and radiofrequency catheter ablation.
15851194 - Catheter ablation guided by termination of postinfarction ventricular tachycardia by pa...
9876324 - Heat stress-induced resistance to myocardial infarction in the isolated heart from tran...
3225064 - Sequential rupture of the left ventricular free wall and of the interventricular septum...
Publication Detail:
Type:  Journal Article     Date:  2010-10-04
Journal Detail:
Title:  Journal of endocrinological investigation     Volume:  34     ISSN:  1720-8386     ISO Abbreviation:  J. Endocrinol. Invest.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-05-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7806594     Medline TA:  J Endocrinol Invest     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  206-15     Citation Subset:  IM    
Affiliation:
Chair and Department of Pharmacology, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland. tadkrzem@ka.onet.pl.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Zona fasciculata 21-hydroxysteroids and precursor-to-product ratios in 21-hydroxylase deficiency: Fu...
Next Document:  Breast conservation therapy in patients with stage t1-t2 breast cancer: current challenges and oppor...